gadolinium

gadolinium is a silvery-white, malleable, and ductile rare-earth element within the lanthanide series of the periodic table. It was discovered in 1880 by the Swiss chemist Jean Charles Galissard de Marignac, who identified its oxide from the mineral gadolinite. The element exhibits unique magnetic properties, becoming strongly ferromagnetic below room temperature, and possesses the highest neutron capture cross-section of any stable nuclide. These characteristics make it invaluable in various technological and medical fields, particularly in magnetic resonance imaging and nuclear reactor control.

Properties

Gadolinium displays intriguing physical and chemical traits that distinguish it among the lanthanides. At temperatures below approximately 20°C (68°F), it undergoes a transition to a ferromagnetic state, a property shared by few other elements like iron, cobalt, and nickel. Its most notable nuclear property is an exceptionally high thermal neutron capture cross-section, primarily due to the isotope gadolinium-157. Chemically, it most commonly exhibits a +3 oxidation state, forming salts such as gadolinium(III) oxide and gadolinium(III) chloride that are typically colorless or pale yellow. The element's electron configuration results in a half-filled 4f subshell, contributing to its stability and influencing its magnetic behavior. In its metallic form, it has a hexagonal close-packed crystal structure at room temperature.

History

The discovery of gadolinium is credited to Jean Charles Galissard de Marignac in 1880, who detected its spectroscopic signature in samples of the mineral gadolinite. He separated an oxide he called "Y_α," which was later confirmed to be gadolinia, the oxide of the new element. The element's name honors the Finnish chemist and geologist Johan Gadolin, a pioneer in the study of rare-earth minerals. The metal itself was first isolated in relatively pure form in 1886 by the French chemist Paul-Émile Lecoq de Boisbaudran. Further purification and characterization continued into the 20th century with advancements in ion-exchange and solvent extraction techniques developed during the Manhattan Project.

Occurrence and production

Gadolinium is never found in nature as a free element but occurs in various rare-earth minerals. Significant sources include monazite and bastnäsite, which are the primary commercial ores for most lanthanides, as well as the namesake mineral gadolinite. Economically viable deposits are found in locations such as the Mountain Pass mine in California, the Bayán Óbo district in Inner Mongolia, and coastal sands in India and Brazil. Industrial production involves complex separation processes, typically beginning with crushing and milling of the ore, followed by acid digestion. Subsequent steps utilize repeated solvent extraction or ion-exchange chromatography to isolate gadolinium salts from other rare-earth elements. The metal is then produced through calcination of its salts to form the oxide, followed by reduction with calcium or other agents in an inert atmosphere.

Applications

The unique properties of gadolinium drive its use in several high-tech and medical applications. In the field of diagnostic medicine, chelated compounds like gadopentetate dimeglumine are widely used as intravenous contrast agents to enhance images in magnetic resonance imaging scans. Its high neutron absorption capability makes it useful in nuclear reactors, where it serves as a burnable poison in control rods and shielding materials. Gadolinium compounds are also integral to the manufacture of phosphors for color television tubes, X-ray intensifying screens, and certain LEDs. Furthermore, alloys containing gadolinium exhibit a strong magnetocaloric effect, making them promising materials for magnetic refrigeration systems near room temperature.

Biological role and precautions

Gadolinium has no known native biological role in any organism. While chelated forms used in MRI are generally considered safe for most patients, significant precautions are necessary. In individuals with severe renal impairment, administration of certain gadolinium-based contrast agents has been linked to the development of nephrogenic systemic fibrosis, a serious and potentially debilitating condition. Consequently, screening for kidney function is standard practice prior to contrast-enhanced MRI. Research into the long-term retention of gadolinium in bodily tissues, including the brain, is ongoing. Occupational exposure to gadolinium dust or fumes in industrial settings is regulated, as with other heavy metals, to prevent potential toxicity.

Category:Chemical elements Category:Lanthanides